[HTML][HTML] Safety, immunogenicity, and protective efficacy against controlled human malaria infection of Plasmodium falciparum sporozoite vaccine in Tanzanian adults
We are using controlled human malaria infection (CHMI) by direct venous inoculation (DVI)
of cryopreserved, infectious Plasmodium falciparum (Pf) sporozoites (SPZ)(PfSPZ Challenge…
of cryopreserved, infectious Plasmodium falciparum (Pf) sporozoites (SPZ)(PfSPZ Challenge…
[HTML][HTML] Controlled human malaria infection of Tanzanians by intradermal injection of aseptic, purified, cryopreserved Plasmodium falciparum sporozoites
Controlled human malaria infection (CHMI) by mosquito bite has been used to assess anti-malaria
interventions in> 1,500 volunteers since development of methods for infecting …
interventions in> 1,500 volunteers since development of methods for infecting …
[HTML][HTML] Immunogenicity and protective efficacy of radiation-attenuated and chemo-attenuated PfSPZ vaccines in Equatoguinean adults
…, A Hamad, E Nyakarungu, M Mpina… - The American journal …, 2021 - ncbi.nlm.nih.gov
Plasmodium falciparum sporozoite (PfSPZ) Vaccine (radiation-attenuated, aseptic, purified,
cryopreserved PfSPZ) and PfSPZ-CVac (infectious, aseptic, purified, cryopreserved PfSPZ …
cryopreserved PfSPZ) and PfSPZ-CVac (infectious, aseptic, purified, cryopreserved PfSPZ …
[HTML][HTML] Safety and differential antibody and T-cell responses to the Plasmodium falciparum sporozoite malaria vaccine, PfSPZ vaccine, by age in Tanzanian adults …
In 2016, there were more cases and deaths caused by malaria globally than in 2015. An
effective vaccine would be an ideal additional tool for reducing malaria’s impact. Sanaria® …
effective vaccine would be an ideal additional tool for reducing malaria’s impact. Sanaria® …
Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults
SE Silk, WF Kalinga, IM Mtaka, NS Lilolime, M Mpina… - Med, 2023 - cell.com
Background RH5 is a leading blood-stage candidate antigen for a Plasmodium falciparum
vaccine; however, its safety and immunogenicity in malaria-endemic populations are unknown…
vaccine; however, its safety and immunogenicity in malaria-endemic populations are unknown…
Antigen-stimulated PBMC transcriptional protective signatures for malaria immunization
Identifying immune correlates of protection and mechanisms of immunity accelerates and
streamlines the development of vaccines. RTS,S/AS01E, the most clinically advanced malaria …
streamlines the development of vaccines. RTS,S/AS01E, the most clinically advanced malaria …
Increase of dose associated with decrease in protection against controlled human malaria infection by PfSPZ Vaccine in Tanzanian adults
Background A vaccine would be an ideal tool for reducing malaria’s impact. PfSPZ Vaccine (radiation
attenuated, aseptic, purified, cryopreserved Plasmodium falciparum [Pf] …
attenuated, aseptic, purified, cryopreserved Plasmodium falciparum [Pf] …
[HTML][HTML] RTS, S/AS01E malaria vaccine induces memory and polyfunctional T cell responses in a pediatric African phase III trial
…, A Ayestaran, AJ Nhabomba, M Mpina… - Frontiers in …, 2017 - frontiersin.org
Comprehensive assessment of cellular responses to the RTS,S/AS01E vaccine is needed
to understand potential correlates and ultimately mechanisms of protection against malaria …
to understand potential correlates and ultimately mechanisms of protection against malaria …
[HTML][HTML] The Equatoguinean malaria vaccine initiative: from the launching of a clinical research platform to malaria elimination planning in Central West Africa
…, A Hamad, C Cortes, T Schindler, M Mpina… - The American journal …, 2020 - ncbi.nlm.nih.gov
Fifteen years of investment in malaria control on Bioko Island, Equatorial Guinea (EG),
dramatically reduced malaria-associated morbidity and mortality, but the impact has plateaued. …
dramatically reduced malaria-associated morbidity and mortality, but the impact has plateaued. …
CD36 deficiency protects against malarial anaemia in children by reducing Plasmodium falciparum‐infected red blood cell adherence to vascular endothelium
Objective CD36 is a receptor that occurs on the surface of activated immune cells, vascular
endothelial cells and participates in phagocytosis and lipid metabolism. CD36 is known to be …
endothelial cells and participates in phagocytosis and lipid metabolism. CD36 is known to be …